Co-Diagnostics, Inc. (CODX) vs Quince Therapeutics, Inc. (QNCX)
A side-by-side comparison of Co-Diagnostics, Inc. and Quince Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CODX
Co-Diagnostics, Inc.
$1.09HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
QNCX
Quince Therapeutics, Inc.
$27.54HealthcareDelayed quote: Oct 6, 2026, 12:28 PM EDT
Total return — CODX vs QNCX
growth of $100 · dividends reinvested · last 7yCODX -96.9% (-39.0%/yr)QNCX -99.6% (-54.1%/yr)CODX compounded faster over this window
Log scale — wide-divergence pair
CODX QNCX
CODX vs QNCX: by the numbers
- •QNCX is the larger company ($8M vs $7M market cap).
- •Both run net losses; QNCX's is the smaller (0.00% vs -6523.04% net margin).
Metrics side by side
Valuation
| Metric | CODX | QNCX |
|---|---|---|
| P/S ratio | 9.40 | N/A |
| P/B ratio | 0.53 | N/A |
Profitability
| Metric | CODX | QNCX |
|---|---|---|
| Gross margin | 64.28% | 0.00% |
| Operating margin | -5025.53% | 0.00% |
| Net margin | -6523.04% | 0.00% |
| ROE | -370.16% | -85.24% |
| ROIC | -219.15% | -107.08% |
Growth (annualized)
| Metric | CODX | QNCX |
|---|---|---|
| Revenue CAGR (5Y) | -62.43% | N/A |
| Total return CAGR (5Y) | -66.53% | -72.96% |
Frequently asked
- How have CODX and QNCX total returns compared?
- Over the past 5 years, CODX delivered -66.53% and QNCX delivered -72.96% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.